Northwest Biotherapeutics, Inc. is a biotechnology company, which engages in the development of personalized immune therapies for cancer. The company is headquartered in Bethesda, Maryland and currently employs 25 full-time employees. The company went IPO on 2001-12-14. The firm is focused on developing personalized immune therapies for cancer. The company has developed a platform technology, DCVax, which uses activated dendritic cells to mobilize a patient's own immune system to attack their cancer. The firm's product line includes DCVax-L and DCVax-Direct. DCVax-L is designed to treat solid tumor cancers in which the tumors can be surgically removed. The company has completed a 331-patient international Phase III trial of DCVax-L for Glioblastoma multiforme brain cancer (GBM). DCVax-Direct is designed to treat inoperable solid tumors. A 40-patient Phase I trial has been completed and includes treatment of a diverse range of more than a dozen types of cancers. Its subsidiaries include Flaskworks LLC, NW Bio GmbH, Northwest Biotherapeutics Capital Limited, Northwest Biotherapeutics B.V., Advent BioServices Ltd., and others.
NWBO stock price ended at $0.3 on viernes, after rising 7.14%
On the latest trading day Jan 16, 2026, the stock price of NWBO rose by 7.14%, climbing from $0.29 to $0.30. During the session, the stock saw a volatility of 7.14%, with prices oscillating between a daily low of $0.28 and a high of $0.30. Notably, trading volume dropped by 1.1M shares on the last day despite the price increase, which may signal a potential uptick in risk in the near term. A total of 3.2M shares were traded, equating to a market value of approximately $458.6M.
Señales Técnicas de NWBO
Resumen de Señales Técnicas
Señales de compra 5
Señales Neutras 2
Señales de venta 0
Strong Sell
Sell
Neutral
Buy
Strong Buy
NWBO actualmente presenta 5 señales de compra y 0 señales de venta. La acción ha estado en una tendencia alcista desde 12:00 AM, con un cambio total en el precio de 7.14% durante este período. En general, los indicadores técnicos apuntan a una perspectiva Strong Buy para el mediano plazo.
Señales alcistas/bajistas para NWBO
Analizamos indicadores clave como medias móviles, RSI, MACD y volumen de negociación para generar señales alcistas y bajistas para NWBO. Estas perspectivas te ayudan a tomar decisiones de inversión más informadas.
Preguntas de seguimiento
¿Cómo se aplican los indicadores de análisis técnico a NWBO?
¿Cuáles son los niveles de retroceso de Fibonacci para NWBO?
¿Cuál es el RSI de Northwest Biotherapeutics Inc?
¿Cuál es el precio de Northwest Biotherapeutics Inc para los próximos 12 meses?
¿Hasta dónde se espera que suba Northwest Biotherapeutics Inc?